Distinctive biology of pleomorphic lobular carcinoma of the breast

Journal of Surgical Oncology

Volumn 90, Issue 2, 2005, Pages 47-50

  Moe, Roger E ^a   Anderson, Benjamin O ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; BRCA2 PROTEIN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TUMOR MARKER;

BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER STAGING; CELL NUCLEUS; CELL ULTRASTRUCTURE; CLINICAL FEATURE; CYTOLOGY; CYTOPLASM; DECISION MAKING; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE COURSE; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PLEOMORPHIC LOBULAR CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

ANDROGENS; APOCRINE GLANDS; BRCA2 PROTEIN; BREAST NEOPLASMS; CADHERINS; CARCINOMA, LOBULAR; CARRIER PROTEINS; FEMALE; GLYCOPROTEINS; HUMANS; METAPLASIA; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL;

EID: 17844363443     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20246     Document Type: Review

References (40)

1. Foote FW, Jr., Stewart FW: Lobular carcinoma in situ: a rare form of mammary cancer. Am J Pathol 1941;17:491-496.
2. Page DL, Anderson TJ: Infiltrating lobular carcinoma. In: Diagnostic histopathology of the breast. New York: Churchill Livingstone; 1987; pp 219-226.
3. Eusebi V, Magalhaes F, Azzopardi JG: Pleomorphic lobular carcinoma of the breast: An aggressive tumor showing apocrine differentiation. Hum Pathol 1992;23:655-662.
4. Weidner N, Semple JP: Pleomorphic variant of lobular carcinoma of the breast. Hum Pathol 1992;23:1167-1171.
5. Henson D, Tarone R: A study of lobular carcinoma of the breast based on the Third National Cancer Survey in the United States of America. Tumori 1979;65:133-142.
6. Moe RE, Anderson BO, Holt SK, et al: The incidence of invasive lobular carcinoma is increasing among postmenopausal women. Proc ASCO 1999;18:73a.
7. Li CI, Anderson BO, Porter P, et al.: Changing incidence rate of invasive lobular carcinoma among older women. Cancer 2000; 88:2561-2569.
8. Li CI, Anderson BO, Daling JH, et al.: Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 2003;289: 1421-1424.
9. Li CI, Malone KE, Porter PL, et al.: Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA 2003;289:3254-3263.
10. Verkooijen HM, Fioretta G, Vlastos G, et al.: Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland. Int J Cancer 2003;104:778-781.
11. Foote FW, Jr., Stewart FW: A histologic classification of carcinoma of the breast. Surgery 1946;19:74-99.
12. Tavassoli FA: Invasive lobular carcinoma. In: Pathology of the breast, 2nd edition. Stamford CN: Appleton & Lange; 1999; pp 426-436.
13. Rosen PP: Invasive lobular carcinoma. In: Rosen's breast pathology, 2nd edition. Philadelphia: Lippincott Williams & Wilkins; 2001; pp 627-652.
14. Abdel-Ghani AS, Wells CA: Immunohistochemical localisation of androgen receptor in apocrine metaplasia and apocrine adenosis of the breast: Relation to oestrogen and progesterone receptors. J Clin Pathol 1999;52:838-841.
15. Haagensen DE, Jr., Dilley WG, Mazoujian G, et al.: Review of GCDFP-15. An apocrine marker protein. Ann N Y Acad Sci 1990; 586:161-173.
16. Haagensen DE, Jr., Mazoujian G: Biochemistry and immunohistochemistry of fluid proteins of the breast in gross cystic disease. In: Diseases of the breast. 3rd edition. Philadelphia PA: W. B. Saunders Company; 1986; pp 474-500.
17. Coradini D, Pellizzaro C, Veneroni S, et al.: Infiltrating ductal and lobular breast carcinomas are characterized by different inter-relationships among markers related to angiogenesis and hormone dependence. B J Cancer 2002;87:1105-1111.
18. Porter PL, Garcia R, Moe R, et al.: C-erbB-2 oncogene protein in in situ and invasive lobular breast cancer. Cancer 1991;68:331-334.
19. Middleton LP, Palacios DM, Bryant BR, et al.: Pleomorphic lobular carcinoma: Morphology, immunohistochemistry, and molecular analysis. Am J Surg Pathol 2000;24:1650-1656.
20. Frolik D, Caduff R, Varga Z: Pleomorphic lobular carcinoma of the breast: Its cell kinetics, expression of oncogenes, and tumor suppressor genes compared with invasive ductal carcinomas and infiltrating lobular carcinomas. Histopathology 2001; 39:503-513.
21. Radhi JM: Immunohistochemical analysis of pleomorphic lobular carcinoma: Higher expression of p53 and chromogranin and lower expression of ER and PgR. Histopathology 2000;36:156-160.
22. Berx G, Cleton-Jansen AM, Strumane K, et al.: E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 1996;13:1919-1925.
23. De Leeuw WJ, Berx G, Vos CB, et al.: Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 1997;183:404-411.
24. Acs G, Lawton TJ, Rebbeck TR, et al.: Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Path 2001;115: 85-98.
25. Sneige N, Wang J, Baker BA, et al.: Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: A report of 24 cases. Mod Pathol 2002; 15:1044-1050.
26. Palacios J, Sarrio D, Garcia-Macias MC, et al.: Frequent E-cadherin gene inactivation of loss of heterozygosity in pleomorphic lobular carcinoma of the breast. Mod Pathol 2003; 16:674-678.
27. Jacobs TW, Pliss N, Kouria G, et al.: Carcinomas in situ of the breast with indeterminate features: Role of E-cadherin staining in categorization. Am J Surg Pathol 2001;25:229-236.
28. Goldstein NS, Bassi D, Watts JC, et al.: E-cadherin reactivity of 95 noninvasive ductal and lobular lesions of the breast. Implications for the interpretation of problematic lesions. Am J Clin Pathol 2001;115:534-542.
29. Armes JE, Egan AJ, Southey MC, et al.: The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA! Or BRCA2 germline mutations: A population-based study. Cancer 1998;83:2251-2254.
30. Yeatman TJ, Cantor AB, Smith TJ, et al.: Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann Surg 1995;222:549-559.
31. DiCostanzo D, Rosen PP, Gareen I, et al.: Prognosis in infiltrating lobular carcinoma. An analysis of "classical" and variant tumors. Am J Surg Pathol 1990;14:12-23.
32. Eusebi V, Magalhaes F, Azzopardi JG: Pleomorphic lobular carcinoma of the breast: An aggressive tumor showing apocrine differentiation. Hum Pathol 1992;23:655-662.
33. Weidner N, Semple JP: Pleomorphic variant of invasive lobular carcinoma of the breast. Hum Pathol 1992;23:1167-1171.
34. Bentz JS, Yassa N, Clayton F: Pleomorphic lobular carcinoma of the breast: Clinicopathologic features of 12 cases. Mod Pathol 1998;11:814-822.
35. Lamovec J, Bracko M: Metastatic pattern of infiltrating lobular carcinoma of the breast: An autopsy study. J Surg Oncol 1991;48: 28-33.
36. Borst MJ, Ingold JA: Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast. Surgery 1993;114: 637-641.
37. Heimann R, Lan F, McBride R, Hellman S: Separating favorable from unfavorable prognostic markers in breast cancer; the role of E-cadherin. Cancer Res 2000;60:298-304.
38. Kneeshaw PJ, Turnbull LW, Smith A, et al.: Dynamic contrast enhanced magnetic resonance imaging aids the surgical management of invasive lobular breast cancer. Eur J Surg Oncol 2003; 29:32-37.
39. Bedrosian I, Mick R, Morel SG, et al.: Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer 2003;98:468-473.
40. Munot K, Dall B, Achuthan R, et al.: Role of magnetic resonance imaging in the diagnosis and single-stage surgical resection of invasive lobular carcinoma of the breast. Br J Surg 2003;89: 1296-1301.